Sources

9 Total Sources

AstraZeneca Holds $400 Billion Merger Talks With Bristol Myers as Antitrust Risks Loom

Left43%

Center29%

Right29%

Financial Times81d ago

AstraZeneca, Bristol Myers Squibb Discuss Potential $400bn Pharma Merger

AskTraders82d ago

AstraZeneca and Bristol Myers Squibb in Merger Talks, FT Reports

AstraZeneca explores Bristol Myers Squibb merger to create nearly $400bn drug group

AstraZeneca Explored Bristol Myers Squibb Acquisition for Megadeal

AstraZeneca, Bristol Myers Squibb in $400 Billion Merger Talks

AstraZeneca Considers $400 Billion Merger with Bristol Myers Squibb

AstraZeneca, Bristol Myers Squibb Explore Potential $400 Billion Merger Talks

Yahoo Finance81d ago

AstraZeneca, Bristol-Myers Squibb Discuss Potential $400 Billion Merger

Seeking Alpha82d ago

AstraZeneca, Bristol Myers held merger talks, Financial Times reports (AZN:NYSE) | Seeking Alpha